Skinvisible Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Skinvisible Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011799
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥28,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥56,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥84,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Skinvisible Pharmaceuticals Inc (Skinvisible Pharmaceuticals), a subsidiary of Skinvisible Inc is a pharmaceutical company that develops and manufactures prescription and over the counter dermatology, medical, cosmetic, consumer goods, and skincare products. The company’s products include anti-aging products, pre-surgical preparations, acne moisturizer, anti-itch spray, foot cream and spray, sunburn relief, antimicrobial hand sanitizing lotions, anti- inflammatory products, topical analgesics and first aid, among others. It uses invisicare technology for topical and mucosal products that binds ingredients to the skin and enhances their delivery. Skinvisible Pharmaceuticals conducts in-house research, development and testing of its invisicare polymer delivery vehicles. It serves pharmaceutical, skincare, cosmetic and consumer goods companies. Skinvisible Pharmaceuticals is headquartered in Las Vegas, Nevada, the US.

Skinvisible Pharmaceuticals Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Skinvisible Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Skinvisible Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Skinvisible Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Skinvisible Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Skinvisible Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Skinvisible Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 10
Merger 10
Skinvisible Pharma Plans to Merge with Quoin Pharma 10
Licensing Agreements 11
Canopy Growth Enters into License Agreement with Skinvisible Pharma 11
CannaSkin Enters into Licensing Agreement with Skinvisible Pharma 12
Skinvisible Pharmaceuticals Inc – Key Competitors 13
Skinvisible Pharmaceuticals Inc – Key Employees 14
Skinvisible Pharmaceuticals Inc – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Product News 16
Jul 07, 2017: Skinvisible Improves the Delivery of Cannabis with Patented Invisicare Technology 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Skinvisible Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts 2
Skinvisible Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Skinvisible Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Skinvisible Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Skinvisible Pharmaceuticals Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Skinvisible Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Skinvisible Pharma Plans to Merge with Quoin Pharma 10
Canopy Growth Enters into License Agreement with Skinvisible Pharma 11
CannaSkin Enters into Licensing Agreement with Skinvisible Pharma 12
Skinvisible Pharmaceuticals Inc, Key Competitors 13
Skinvisible Pharmaceuticals Inc, Key Employees 14

★海外企業調査レポート[Skinvisible Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • National Human Genome Research Institute(製薬・医療分野):企業M&A動向
    Summary National Human Genome Research Institute (NHGRI) is a research organization. The organization conducts research on human genome. Its research programs and projects include clinical sequencing exploratory research, functional analysis program, genome technology program, the NHGRI genome seque …
  • HTL International Holdings Limited:企業の戦略的SWOT分析
    HTL International Holdings Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Cliffs Natural Resources Inc.:企業のM&A・提携・投資分析
    Cliffs Natural Resources Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cliffs Natural Resources Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Innogene Kalbiotech Pte. Ltd.(製薬・医療分野):企業M&A動向
    Summary Innogene Kalbiotech Pte. Ltd. (Innogene) is a biotechnology company. The company develops therapeutics and medical diagnostics in the field of critical care and oncology. Its products include racotumomab, totilac, hemapo, kalferon, mediflex, leucogen, kalparin, lanzox, hepavax gene, vivotif, …
  • SAP SE:企業の戦略・SWOT・財務分析
    SummarySAP SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - Detai …
  • EnLink Midstream Partners, LP (formerly Crosstex Energy, L.P.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' EnLink Midstream Partners, LP ( …
  • MRI Interventions Inc (MRIC):企業のM&A・提携動向(医療機器分野)
    Summary MRI Interventions Inc (MRI Interventions) is a medical device company that develops and commercializes platforms for invasive surgical procedures. The company’s product platforms include ClearPoint system, which is used for minimally invasive surgical procedures in the brain; and ClearTrace …
  • Mapletree Investments Pte, Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Mapletree Investments Pte, Ltd. …
  • Great Eagle Holdings Limited:企業の戦略・SWOT・財務分析
    SummaryGreat Eagle Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company …
  • Vornado Realty Trustの企業概要及び財務/SWOT分析
    Vornado Realty Trust Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, Vornado Realty Trust annual and quarterly forecasts made by stock market experts. The report also enables …
  • Hubei Guangji Pharmaceutical Co., Ltd. (000952):企業の財務及び戦略的SWOT分析
    Summary Hubei Guangji Pharmaceutical Co., Ltd. (GJPC) is a pharmaceutical company that develops ingredients. The company manufactures and markets pharmaceutical raw materials. Its product categories include active pharmaceutical ingredients, human nutrition and animal nutrition. GJPC’s products incl …
  • CrystalGenomics, Inc. (083790):企業概要、財務及び戦略的SWOT分析
    Summary CrystalGenomics, Inc.(CrystalGenomics) is a biopharmaceutical company.The company discovers and develops drugs based on structural chemoproteomics. Its products include next generation NSAID, novel antibiotic against MRSA and VRSA, and molecular targeted cancer therapeutic. CrystalGenomics’ …
  • Worldpay Group PLC:企業の戦略・SWOT・財務分析
    SummaryWorldpay Group PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Find …
  • EBM Technologies Incorporated (8409):企業概要、財務及び戦略的SWOT分析
    Summary EBM Technologies (EBM) is a healthcare information technology company. The company develops and delivers web-based technologies and progressive customizable diagnostic tools. Its products include EBM diagnostic and reviewing station, EBM online PACS, EBM storage and utility server, EBM gatew …
  • First Republic Private Wealth Management:企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "First Republic Private Wealth Management" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. We …
  • Hybio Pharmaceutical Co., Ltd. (300199):企業の財務及び戦略的SWOT分析
    Summary Hybio Pharmaceutical Co., Ltd. (Hybio) is a bio-pharmaceutical company that develops polypeptide drugs. The company manufactures and develops peptide finished dosage products and peptide active pharmaceutical ingredients. Its finished dosage products include desmopressin for injection, terli …
  • Dev Information Technology Limited (DEVIT):企業の財務・戦略的SWOT分析
    Dev Information Technology Limited (DEVIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • HTC Corporation:企業の戦略・SWOT・財務分析
    SummaryHTC Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Finding …
  • Slacker, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Slacker, Inc. Mergers and Acqui …
  • Sequa Petroleum NV (MLSEQ):企業財務及び戦略的SWOT分析
    Summary Sequa Petroleum NV (Sequa Petroleum) is an oil and gas company that focuses on taking discovered oil and gas reserves and resources from appraisal through to production. The company’s activities include acquisition, appraisal, financing, development, production and monetisation of oil and ga …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆